Title:Corporate Compliance in the Life Sciences: Anti-Bribery + Anti-Corruption Best Practices
Content:
In many emerging markets, a growing middle class is wielding its discretionary income to demand a wider array of healthcare services. The worldwide aging population is also becoming a powerful buying group with its own health requirements.
